Person: KALKAN, SENAD
6 results
Search Results
Now showing 1 - 6 of 6
Publication Metadata only C-reactive protein and Procalcitonin levels in Prostate Cancer.(2020-12-16T00:00:00Z) Kalkan, Senad; Çalışkan, Selahattin; İLKTAÇ, ABDULLAH; KALKAN, SENADPublication Metadata only The optimal settings of holmium YAG laser in treatment of pediatric urolithiasis.(2021-01-21T00:00:00Z) Ersoz, Cevper; Ilktac, ABDULLAH; Kalkan, Senad; Danacioglu, Yavuz Onur; Silay, Mesrur Selcuk; ERSÖZ, CEVPER; İLKTAÇ, ABDULLAH; DOĞAN, BAYRAM; KALKAN, SENADThe aim of this study is to present our experience on the use of the holmium:yttrium-aluminum-garnet (Ho:YAG) laser in pediatric patients for pediatric urolithiasis and describe the optimal settings. A total of 116 children who underwent urolithiasis treatment (percutaneous nephrolithotomy (PNL), ureterorenoscopy (URS), retrograde intrarenal surgery (RIRS)) were included. The mean age of the patients was 8.4 ± 5.2 years (1-18). The mean follow-up was 26 ± 8.8 months (9-45). There was no difference between the mean stone sizes of PNL and RIRS patients (p = 0.816). Operations were performed with 200, 272, and 365-μm fibers. In mini-URS, stone fragmentation was achieved with the energy settings set between 0.5 and 1 J and frequency set to > 8 Hz. In RIRS, fragmentation was achieved with the setting of 0.5-0.8 J at 10-20 Hz. Stone fragmentation was performed with energy settings of 0.8 to 2 J between 5 and 15 Hz for PNL. There was no significant difference between the stone-free rates of the PNL and RIRS (p = 0.150). Four postoperative complications occurred (Clavien II), which included febrile urinary infections in two patients who underwent mini-URS, one patient who underwent PNL, and one patient who underwent RIRS. Our results confirmed that Ho-YAG laser can be effectively used in children for stone treatment by using low-energy high-frequency settings for URS and RIRS and a high energy setting for PNL.Publication Unknown Tam Üretral Rüptüre Eşlik Eden Penil Kırıkların Cerrahi Tedavisi(2022-02-01T00:00:00Z) Ersöz, Cevper; İlktaç, Abdullah; Çolakoğlu, Yunus; Şimşek, Abdulmuttalip; Kalkan, Senad; ERSÖZ, CEVPER; İLKTAÇ, ABDULLAH; KALKAN, SENADPublication Metadata only Lokalize Prostat Kanserinde Kalıcı Brakiterapi Deneyimimiz(2020-03-01T00:00:00Z) İlktaç, Abdullah; Kalkan, Senad; İLKTAÇ, ABDULLAH; KALKAN, SENADPublication Metadata only Is Sexual Function in Female Partners of Men With Premature Ejaculation Compromised?(2015-07-04T00:00:00Z) KAYA, CEVDET; Gunes, Mustafa; Gokce, Ali Murat; Kalkan, Senad; KALKAN, SENADThe authors enrolled 32 female partners of sexually active men with premature ejaculation to investigate their sexual functions. An age-matched sample of the same number women whose partners had no sexual dysfunction was also included. Premature ejaculation was defined for all participants as ejaculation that nearly always occurs before or within 2min of vaginal penetration. An invitation letter was given to men with premature ejaculation to ask whether their female partners could be contacted about completing a questionnaire to measure female sexual status. On the basis of the Female Sexual Function Index, the average sexual function score was significantly lower in partners of men with premature ejaculation (21.8 +/- 7.6) compared with that in healthy controls (25.9 +/- 6.6). Female sexual dysfunction was diagnosed in 78% of women who has a male partner with premature ejaculation, while 40% of female partner of healthy men. All of the domain scores of Female Sexual Function Index, except the desire and pain levels, were significantly lower in female partners of men with premature ejaculation group than those of healthy subjects.Publication Metadata only Factors predicting the success of intradetrusor onabotulinum toxin-A treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort.(2021-02-23T00:00:00Z) Danacioglu, Yavuz Onur; Keser, Ferhat; Ersoz, CEVPER; Polat, Salih; Avci, Ali Egemen; Silay, Mesrur Selcuk; ERSÖZ, CEVPER; KALKAN, SENAD